| mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.082 |
0.8 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.26 |
0.4 |
| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.29 |
0.3 |
| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.33 |
0.3 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
1.8e-05 |
1 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.00012 |
1 |
| mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.00031 |
1 |
| mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.0004 |
1 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00052 |
1 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00058 |
1 |